Scott A. Waldman, MD, PhD

Contact Dr. Waldman

132 South Tenth Street
1170 Main Building
Philadelphia, PA 19107

(215) 955-6086
(215) 955-5681 fax

Most Recent Peer-reviewed Publications

  1. Prenatal Regeneration in Clinical Practice
  2. Guanylate cyclase-C as a therapeutic target in gastrointestinal disorders
  3. First-in-Human Use of a Retention-Enhanced Catheter for Endomyocardial Cell Delivery
  4. Process Improvement for Maximized Therapeutic Innovation Outcome
  5. GUCY2C signaling opposes the acute radiation-induced GI syndrome
  6. ST-producing E. Coli oppose carcinogen-induced colorectal tumorigenesis in mice
  7. Peer Review Certifies Quality and Innovation in Clinical Pharmacology & Therapeutics
  8. Bioactivity of oral linaclotide in human colorectum for cancer chemoprevention
  9. Guanylate cyclase C as a target for prevention, detection, and therapy in colorectal cancer
  10. Prime-boost immunization eliminates metastatic colorectal cancer by producing high-Avidity effector CD8+T cells
  11. Clinical Pharmacology & Therapeutics: Past, Present, and Future
  12. Cardiopoietic cell therapy for advanced ischaemic heart failure: Results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial
  13. Managing Innovation to Maximize Value Along the Discovery-Translation-Application Continuum
  14. EXECUTIVE INTERVIEW - Viral gene: Protein-targeting cancer vaccine could boost survival rates
  15. GUCY2C maintains intestinal LGR5+stem cells by opposing ER stress
  16. Multiregion whole-exome sequencing of matched primary and metastatic tumors revealed genomic heterogeneity and suggested polyclonal seeding in colorectal cancer metastasis
  17. Preclinical Evaluation of a Replication-Deficient Recombinant Adenovirus Serotype 5 Vaccine Expressing Guanylate Cyclase C and the PADRE T-helper Epitope
  18. A survey of physician receptivity to molecular diagnostic testing and readiness to act on results for early-stage colon cancer patients
  19. GUCY2C-directed CAR-T cells oppose colorectal cancer metastases without autoimmunity
  20. Guanylyl cyclase C signaling axis and colon cancer prevention